...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of women’s health >Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives
【24h】

Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives

机译：没有用处方药物治疗绝经后骨质疏松症的妇女的原因：医生和患者的观点

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: In the United States, between one-third and two thirds of postmenopausal women do not begin treatment with a prescription osteoporosis medication after a diagnosis of osteoporosis. The objective of this study was to understand the reasons for this lack of treatment. Materials and Methods: Online physician and patient surveys were administered in 2013. The physician survey included a chart review of untreated postmenopausal women recently diagnosed with osteoporosis and gathered data on physicians' practices regarding the management of osteoporosis in postmenopausal women. The patient survey was given to untreated postmenopausal women with a recent osteoporosis diagnosis. Results: The physician survey was completed by 224 physicians, who also reviewed 811 patient charts. A total of 165 patients completed the patient survey. In the chart review, physicians reported that 19% of the postmenopausal women they diagnosed with osteoporosis were not prescribed an osteoporosis medication. The patient declined a physician's recommendation for pharmacological treatment in 81% and 52% of cases in the physician and patient surveys, respectively. The most frequent reasons for physicians not recommending treatment were: low calcium and/or vitamin D levels, patients potentially at risk of medication side effects, pre-existing gastrointestinal problems, and polypharmacy. The most frequent reasons for patients deciding against treatment were: concerns about side effects, considering nonprescription options and behavioral modifications, and questioning the potential benefit of taking the medication. Conclusions: Patients decided against pharmacological treatment of newly diagnosed osteoporosis in at least half of the cases of nontreatment. The principal reasons for not being treated with a prescription medication, given by both physicians and patients, were that there were alternatives and concern about the risks of prescription medications.
机译：背景：在美国，在诊断骨质疏松症后，在美国绝经后妇女的三分之一和三分之二的绝经后妇女不开始治疗骨质疏松药物治疗。本研究的目的是了解这种缺乏治疗的原因。材料和方法：2013年在线管理局进行。患者调查是患有最近骨质疏松症诊断的未经治疗的绝经后妇女。结果：医师调查由224名医生完成，他还审查了811名患者图表。共有165名患者完成患者调查。在图表审查中，医生报告称，19％的患有骨质疏松症的绝经后妇女没有规定骨质疏松症药物。患者分别拒绝了医生在81％和52％的医生和患者调查中的药理治疗方面的建议。医生不推荐治疗的最常见原因是：低钙和/或维生素D水平，患者可能面临药物副作用的风险，预先存在的胃肠道问题和多药物。决定治疗的患者的最常见原因是：关于副作用的担忧，考虑到非前言选择和行为修改，并质疑服用药物的潜在益处。结论：患者在至少一半的非处理病例中反对新诊断骨质疏松症的药理治疗。由医生和患者提供的不治疗处方药治疗的主要原因是有替代和关注的处方药风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号